Capital Fund Management (CFM)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,000
Closed -$581K 1696
2020
Q1
$581K Buy
4,000
+1,100
+38% +$183K 0.01% 982
2019
Q4
$495K Sell
2,900
-5,200
-64% -$964K ﹤0.01% 1395
2019
Q3
$1.44M Buy
8,100
+2,100
+35% +$454K 0.01% 896
2019
Q2
$1.56M Buy
6,000
+5,200
+650% +$1.38M 0.01% 875
2019
Q1
$228K Sell
800
-9,200
-92% -$3.06M ﹤0.01% 1544
2018
Q4
$3.25M Buy
10,000
+100
+1% +$34.7K 0.03% 660
2018
Q3
$4.45M Buy
9,900
+5,000
+102% +$1.97M 0.02% 812
2018
Q2
$2M Buy
4,900
+3,500
+250% +$1.27M 0.01% 1070
2018
Q1
$407K Buy
+1,400
New +$355K ﹤0.01% 1528
2017
Q1
Sell
-4,100
Closed -$462K 1928
2016
Q4
$462K Buy
+4,100
New +$475K ﹤0.01% 1288

Other funds holding ABMD

Capital Fund Management (CFM)'s ABMD Position: Q4 2022 in Review

Capital Fund Management (CFM) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 36,772 shares — an estimated $9.03M sold.

Capital Fund Management (CFM) first reported a position in ABMD in Q2 2014 and held it in 21 quarters. The position peaked at $13.3M in Q4 2015. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Capital Fund Management (CFM) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 36,772 Abiomed Inc shares in Q4 2022, an estimated $9.03M.
  • Capital Fund Management (CFM) first reported a position in Abiomed Inc in Q2 2014 and held it in 21 quarters.
  • Capital Fund Management (CFM)'s Abiomed Inc position peaked at $13.3M in Q4 2015.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2022, filed 13 Feb 2023.